title: Does addition of temozolomide to whole brain radiotherapy improve outcome in patients with brain metastases?
authors.affiliation: University of Edinburgh and Edinburgh Centre for Neuro-Oncology, Edinburgh, UK. serridge@staffmail.ed.ac.uk
authors.forename: Sara C
authors.initials: SC
authors.lastname: Erridge
authors.forename: Anna
authors.initials: A
authors.lastname: Gregor
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy* / Q000556:secondary; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D016371:Cranial Irradiation; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D000077204:Temozolomide
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide